1-methylpyridinium has been researched along with Liver Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chatsudthipong, V; Jinakote, M; Ontawong, A; Pasachan, T; Pimta, J; Soodvilai, S; Srimaroeng, C | 1 |
1 other study(ies) available for 1-methylpyridinium and Liver Neoplasms
Article | Year |
---|---|
High affinity of 4-(4-(dimethylamino)styryl)-N-methylpyridinium transport for assessing organic cation drugs in hepatocellular carcinoma cells.
Topics: Biological Transport; Carcinoma, Hepatocellular; Cations; Cell Line, Tumor; Hep G2 Cells; Hepatocytes; Humans; Liver Neoplasms; Metformin; Organic Cation Transporter 1; Organic Cation Transporter 2; Paclitaxel; Pyridinium Compounds | 2020 |